AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,462 | +13.9% | 164 | +17.1% | 0.00% | 0.0% |
| Q2 2023 | $10,061 | +20.8% | 140 | +3.7% | 0.00% | 0.0% |
| Q1 2023 | $8,327 | -20.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $10,413 | +73.6% | 135 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | +20.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | +66.7% | 135 | +107.7% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 65 | -68.6% | 0.00% | -100.0% |
| Q4 2021 | $8,000 | +14.3% | 207 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | 0.0% | 200 | +85.2% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | +16.7% | 108 | -2.7% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | -25.0% | 111 | +11.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |